# Study Evaluating Safety And Tolerability, Solid Tumor

> **NCT00768469** · PHASE1 · COMPLETED · sponsor: **Puma Biotechnology, Inc.** · enrollment: 10 (actual)

## Conditions studied

- Advanced Malignant Solid Tumors

## Interventions

- **DRUG:** Neratinib
- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT00768469
- **Lead sponsor:** Puma Biotechnology, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2018-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00768469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00768469, "Study Evaluating Safety And Tolerability, Solid Tumor". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00768469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*